177 related articles for article (PubMed ID: 36181033)
41. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
[TBL] [Abstract][Full Text] [Related]
42. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
[TBL] [Abstract][Full Text] [Related]
43. A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
Zheng Y; Xu J; Lin J; Lin Y
Comput Math Methods Med; 2022; 2022():8003525. PubMed ID: 35844445
[TBL] [Abstract][Full Text] [Related]
44. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
[TBL] [Abstract][Full Text] [Related]
45. An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma.
Tang C; Qu G; Xu Y; Yang G; Wang J; Xiang M
Aging (Albany NY); 2021 Dec; 13(24):26046-26062. PubMed ID: 34954690
[TBL] [Abstract][Full Text] [Related]
46. A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma.
Lin L; Wu XH; Zhu JM; Chen SH; Chen YH; Lin F; Xue XY; Wei Y; Xu N; Zheng QS; Sun XL
Comb Chem High Throughput Screen; 2023; 26(8):1503-1518. PubMed ID: 36165528
[TBL] [Abstract][Full Text] [Related]
47. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
48. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
[No Abstract] [Full Text] [Related]
49. A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer.
Jin Y; Li J; Tang C; He K; Shan D; Yan S; Deng G
Medicine (Baltimore); 2023 May; 102(18):e33664. PubMed ID: 37145007
[TBL] [Abstract][Full Text] [Related]
50. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma.
Liu JW; Supandi F; Dhillon SK
Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853
[TBL] [Abstract][Full Text] [Related]
51. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
52. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis.
Chang P; Bing Z; Tian J; Zhang J; Li X; Ge L; Ling J; Yang K; Li Y
Medicine (Baltimore); 2018 Nov; 97(44):e12679. PubMed ID: 30383629
[TBL] [Abstract][Full Text] [Related]
54. A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
Zhang W; Wang H; Wang W; Xue H; Qiao M; Song L; Wang S; Ren Z; Ma Z
Anal Cell Pathol (Amst); 2022; 2022():4673514. PubMed ID: 36588797
[TBL] [Abstract][Full Text] [Related]
55. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
56. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
Sun YF; Chen L; Xia QJ; Wang TH
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345
[TBL] [Abstract][Full Text] [Related]
57. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
58. A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.
Lv J; Xu Q; Wu G; Hou J; Yang G; Tang C; Qu G; Xu Y
Front Genet; 2022; 13():948254. PubMed ID: 36212132
[No Abstract] [Full Text] [Related]
59. Prognostic value of a gene signature in clear cell renal cell carcinoma.
Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
[TBL] [Abstract][Full Text] [Related]
60. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]